Literature DB >> 16283487

Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine.

Hiroko Yoshino1, Mitsuru Futakuchi, Young-Man Cho, Kumiko Ogawa, Fumitaka Takeshita, Norio Imai, Seiko Tamano, Tomoyuki Shirai.   

Abstract

Previously, we established the in vivo lung metastasis model of rat HCC induced by two hepatocarcinogens, diethylnitrosamine (DEN) and N-nitrosomorpholine (NMOR) at a dose of 120 ppm. This model allows us to investigate modifying factors leading to the inhibition of metastasis formation. However, low survival rates made the evaluation of metastasis formation difficult. The current experiments were conducted to modify the experimental protocol to improve survival and to establish a better animal metastasis model. Lower doses of NMOR (80 or 40 ppm in drinking water) were given to F344 rats for 14 weeks after DEN treatment. Survival rates in the 80 ppm group and in the 40 ppm group were 57% and 81%, respectively and these values were significantly higher than that in 120 ppm. Incidences of lung metastasis in the 40 ppm group steadily increased up to 67% by week 36 while that in the 80 ppm increased sharply up to 86% by week 24. Severity of lung metastases in the 40 ppm group at week 36 was mild compared with the 80 ppm group at week 24. In the second experiment, in order to characterize HCC development and lung metastasis in the 40 ppm group, rats given DEN and then followed with 40 ppm NMOR were killed sequentially. Development of HCC was observed at week 14 and reached 100% incidence at week 20. First lung metastatic lesions were evident at week 22, and incidence of lung metastasis reached 100%. Tumor cells were identified in the blood at week 20 by RT-PCR. The current study revealed that 40 ppm NMOR for 14 weeks after DEN treatment developed HCC without lung metastases at week 22, then HCC with a frequent lung metastasis at week 40. Thus, it can be said that this system is a more appropriate model for elucidation of mechanisms of metastasis and also for analysis of factors to inhibit natural metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283487     DOI: 10.1007/s10585-005-2807-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  26 in total

Review 1.  Critical determinants of metastasis.

Authors:  Isaiah J Fidler
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

2.  Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.

Authors:  K Lapis; I Sarosi; J Bocsi; U P Thorgeirsson
Journal:  Lab Invest       Date:  1995-06       Impact factor: 5.662

Review 3.  The role of endothelial cells in tumor invasion and metastasis.

Authors:  N Jahroudi; J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 4.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

5.  Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma.

Authors:  Mitsuru Futakuchi; Kumiko Ogawa; Seiko Tamano; Seishiro Takahashi; Tomoyuki Shirai
Journal:  Cancer Sci       Date:  2004-01       Impact factor: 6.716

6.  Bikunin plus paclitaxel markedly reduces tumor burden and ascites in mouse model of ovarian cancer.

Authors:  Hiroshi Kobayashi; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Mika Suzuki; Naohiro Kanayama; Toshihiko Terao
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

7.  Metastasizing tumors in rats treated with alkylating carcinogens.

Authors:  W Lijinsky
Journal:  Carcinogenesis       Date:  1995-04       Impact factor: 4.944

Review 8.  Development and prevention of metastasis.

Authors:  E C Kohn
Journal:  Anticancer Res       Date:  1993 Nov-Dec       Impact factor: 2.480

9.  Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler.

Authors:  Seiji Ito; Hayao Nakanishi; Takashi Hirai; Tomoyuki Kato; Yasuhiro Kodera; Zhang Feng; Yasushi Kasai; Katsuki Ito; Seiji Akiyama; Akimasa Nakao; Masae Tatematsu
Journal:  Cancer Lett       Date:  2002-09-26       Impact factor: 8.679

10.  Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.

Authors:  M Matsumura; Y Niwa; N Kato; Y Komatsu; S Shiina; T Kawabe; T Kawase; H Toyoshima; M Ihori; Y Shiratori
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  9 in total

1.  Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma.

Authors:  Wei Wang; Wei-Dong Jia; Ge-Liang Xu; Zhi-Hua Wang; Jian-Sheng Li; Jin-Liang Ma; Yong-Sheng Ge; Sheng-Xue Xie; Ji-Hai Yu
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

2.  The distribution of liver cancer stem cells correlates with the mechanical heterogeneity of liver cancer tissue.

Authors:  Yuchuan Sun; Hong Li; Qiufang Chen; Qing Luo; Guanbin Song
Journal:  Histochem Cell Biol       Date:  2021-03-12       Impact factor: 4.304

Review 3.  Hepatocellular carcinoma: insight from animal models.

Authors:  Yan Li; Zhao-You Tang; Jin-Xuan Hou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

4.  Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.

Authors:  Naomi Hokaiwado; Makoto Asamoto; Mitsuru Futakuchi; Kumiko Ogawa; Satoru Takahashi; Tomoyuki Shirai
Journal:  J Membr Biol       Date:  2007-11-03       Impact factor: 1.843

Review 5.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

6.  Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.

Authors:  Sameh Saber; Amr Mahmoud; Noha Helal; Eman El-Ahwany; Rasha Abdelghany
Journal:  Open Access Maced J Med Sci       Date:  2018-06-06

7.  Establishment of rat liver cancer cell lines with different metastatic potential.

Authors:  Lei Song; Jian-Gang Zhang; Long Zheng; Xu Feng; Jie Hou; Huan-Ling Zhang; Shu-Feng Liu
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

8.  Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.

Authors:  Andrea J Moreira; Graziella Rodrigues; Silvia Bona; Carlos Thadeu Cerski; Claudio A Marroni; Jose L Mauriz; Javier González-Gallego; Norma P Marroni
Journal:  Toxicol Rep       Date:  2014-11-28

Review 9.  Genetically Engineered Mouse Models for Liver Cancer.

Authors:  Kyungjoo Cho; Simon Weonsang Ro; Sang Hyun Seo; Youjin Jeon; Hyuk Moon; Do Young Kim; Seung Up Kim
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.